Reviews on Long COVID: A scope of the literature: Update October 2023

Claire Louise Khouja; Gary Austin Raine; Meena Khatwa; Melissa Harden; Katy Sutcliffe; Amanda Jayne Sowden

Reviews on Long COVID: A scope of the literature: Update October 2023

Claire Louise Khouja, Gary Austin Raine, Meena Khatwa, Melissa Harden, Katy Sutcliffe, Amanda Jayne Sowden

Centre for Reviews and Dissemination

Research output: Book/Report › Commissioned report

Abstract

• For this update, we identified 46 published reviews and 44 review protocols for Long COVID. The number of published reviews has increased since our last two quarterly reports in April (n=37) and July (n=31).
• Most published reviews were focused on the prevalence of symptoms or effects (20/46), which is consistent with the earlier reports.
• We identified fewer published reviews with a primary focus on Long COVID risk factors (1/46) than in July (6/31), and more on treatment or rehabilitation (n=11 vs n=5 in July).
• We identified more reviews on pathobiology or mechanisms (n=6) compared with July (n=1).
• Most of the protocols were focused on the prevalence of symptoms or effects (24/44), unlike in the three previous reports, where more protocols were focused on treatment or rehabilitation.
• Most of the other protocols were focused on treatment (8/44), or risk factors with or without prevalence (7/44).

Original language	English
Place of Publication	London
Publisher	EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London.
Commissioning body	NIHR Policy Research Programme
Number of pages	33
ISBN (Print)	978-1-911605-51-5
Publication status	Published - 19 Dec 2023

Bibliographical note

Access to Document

Review_update_Oct23_211223-LO
© Copyright 2023. Authors of the systematic reviews on the EPPI Centre website (http://eppi.ioe.ac.uk/) hold the copyright for the text of their reviews. The EPPI Centre owns the copyright for all material on the website it has developed, including the contents of the databases, manuals, and keywording and data-extraction systems. The centre and authors give permission for users of the site to display and print the contents of the site for their own non-commercial use, providing that the materials are not modified, copyright and other proprietary notices contained in the materials are retained, and the source of the material is cited clearly following the citation details provided. Otherwise, users are not permitted to duplicate, reproduce, re-publish, distribute, or store material from this website without express written permission.
Final published version, 956 KBLicence: CC BY-NC

Cite this

@book{ed00a231898842cf8c63ad202ff35157,

title = "Reviews on Long COVID: A scope of the literature: Update October 2023",

abstract = "• For this update, we identified 46 published reviews and 44 review protocols for Long COVID. The number of published reviews has increased since our last two quarterly reports in April (n=37) and July (n=31).• Most published reviews were focused on the prevalence of symptoms or effects (20/46), which is consistent with the earlier reports. • We identified fewer published reviews with a primary focus on Long COVID risk factors (1/46) than in July (6/31), and more on treatment or rehabilitation (n=11 vs n=5 in July).• We identified more reviews on pathobiology or mechanisms (n=6) compared with July (n=1).• Most of the protocols were focused on the prevalence of symptoms or effects (24/44), unlike in the three previous reports, where more protocols were focused on treatment or rehabilitation.• Most of the other protocols were focused on treatment (8/44), or risk factors with or without prevalence (7/44).",

author = "Khouja, {Claire Louise} and Raine, {Gary Austin} and Meena Khatwa and Melissa Harden and Katy Sutcliffe and Sowden, {Amanda Jayne}",

year = "2023",

month = dec,

day = "19",

language = "English",

isbn = "978-1-911605-51-5",

publisher = "EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London.",

}

TY - BOOK

T1 - Reviews on Long COVID: A scope of the literature

T2 - Update October 2023

AU - Khouja, Claire Louise

AU - Raine, Gary Austin

AU - Khatwa, Meena

AU - Harden, Melissa

AU - Sutcliffe, Katy

AU - Sowden, Amanda Jayne

PY - 2023/12/19

Y1 - 2023/12/19

N2 - • For this update, we identified 46 published reviews and 44 review protocols for Long COVID. The number of published reviews has increased since our last two quarterly reports in April (n=37) and July (n=31).• Most published reviews were focused on the prevalence of symptoms or effects (20/46), which is consistent with the earlier reports. • We identified fewer published reviews with a primary focus on Long COVID risk factors (1/46) than in July (6/31), and more on treatment or rehabilitation (n=11 vs n=5 in July).• We identified more reviews on pathobiology or mechanisms (n=6) compared with July (n=1).• Most of the protocols were focused on the prevalence of symptoms or effects (24/44), unlike in the three previous reports, where more protocols were focused on treatment or rehabilitation.• Most of the other protocols were focused on treatment (8/44), or risk factors with or without prevalence (7/44).

AB - • For this update, we identified 46 published reviews and 44 review protocols for Long COVID. The number of published reviews has increased since our last two quarterly reports in April (n=37) and July (n=31).• Most published reviews were focused on the prevalence of symptoms or effects (20/46), which is consistent with the earlier reports. • We identified fewer published reviews with a primary focus on Long COVID risk factors (1/46) than in July (6/31), and more on treatment or rehabilitation (n=11 vs n=5 in July).• We identified more reviews on pathobiology or mechanisms (n=6) compared with July (n=1).• Most of the protocols were focused on the prevalence of symptoms or effects (24/44), unlike in the three previous reports, where more protocols were focused on treatment or rehabilitation.• Most of the other protocols were focused on treatment (8/44), or risk factors with or without prevalence (7/44).

M3 - Commissioned report

SN - 978-1-911605-51-5

BT - Reviews on Long COVID: A scope of the literature

PB - EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London.

CY - London

ER -